Dr Reddy's CEO Erez Israeli says the pivot is already visible - India and Europe growth is now driven by innovation, consumer ...

Novartis "can never be done" when it comes to major acquisitions in its sector as it always needs to look for the next "great ...

Eli Lilly (LLY) stock has continued its gradual ascent this month, building on a year marked by steady performance. Investors ...

Decision is a setback for Dr. Reddy’s Laboratories, which was poised to be one of the first generic competitors to Ozempic ...

However, sentiment ahead of Q3 appears cautious—in the past three months, EPS estimates have seen 17 downward revisions ...

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

Pharma giant Eli Lilly tapped Walmart to offer in-store pickups of Zepbound vials, marking the first retail collaboration for ...

Spot shows folks running as a symbol of how the health-challenged can chase their dreams because of Sanofi meds.

As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...

Eli Lilly and computing giant Nvidia are teaming up to build a new supercomputer that the pair say will be the most powerful owned and operated by a pharmaceutical company.

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. Read more here.

Eli Lilly and Company said the partnership will result in the build of the most powerful supercomputer owned by a ...